RRR Red Rock tops Q4 2025 EPS estimates by wide margin shares fall 272 percent in todays session CTXR Citius Pharma drops 327 after its wider than expected Q4 2025 EPS misses analyst estimates by 45 Union Pacific UNP Regulatory Scrutiny of Norfolk Southern Merger Poses Event Risk Amid Strong Fundamentals Gilead Sciences GILD Q1 2026 Earnings Analysis Revenue Beats Forecast Amid Mixed Product Performance Why Research Solutions RSSS could be the anchor your portfolio needs Risk Aversion 20260506 What Cadiz CDZIP does better than 90 of companies In Focus 20260505 Nike Inc NKE Q3 FY2026 Results Disappoint Sparking Debate Over DipBuying Opportunity Amid Extended Turnaround Timeline TPTA Terra management remains confident in portfolio performance despite market headwinds highlights strategic priorities for growth